These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37903548)

  • 21. Antiandrogenic mechanisms of pesticides in human LNCaP prostate and H295R adrenocortical carcinoma cells.
    Robitaille CN; Rivest P; Sanderson JT
    Toxicol Sci; 2015 Jan; 143(1):126-35. PubMed ID: 25324206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
    McGregor N; Patel L; Craig M; Weidner S; Wang S; Pienta KJ
    J Cell Biochem; 2010 Aug; 110(5):1187-94. PubMed ID: 20589722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells.
    Yeap BB; Krueger RG; Leedman PJ
    Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonistic action of a synthetic androgen ligand mediated by chromatin remodeling in a human prostate cancer cell line.
    Sawada T; Kanemoto Y; Amano R; Hayakawa A; Kurokawa T; Mori J; Kato S
    Biochem Biophys Res Commun; 2022 Jul; 612():110-118. PubMed ID: 35523048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emodin induces apoptosis in human prostate cancer cell LNCaP.
    Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
    Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.
    Xu D; Lin TH; Li S; Da J; Wen XQ; Ding J; Chang C; Yeh S
    Cancer Lett; 2012 Mar; 316(1):11-22. PubMed ID: 22154085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands.
    Risek B; Bilski P; Rice AB; Schrader WT
    Mol Endocrinol; 2008 Sep; 22(9):2099-115. PubMed ID: 18562628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.
    Mohler JL; Titus MA; Bai S; Kennerley BJ; Lih FB; Tomer KB; Wilson EM
    Cancer Res; 2011 Feb; 71(4):1486-96. PubMed ID: 21303972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
    Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
    Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
    Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
    Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
    He J; Lan X; Duan HL; Luo H; Zhou XD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B; Mayer D
    Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
    Amirghofran Z; Monabati A; Gholijani N
    Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
    Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
    Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG
    Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of androgen receptor in two patient-derived xenograft models of triple negative breast cancer.
    Wang X; Petrossian K; Huang MJ; Saeki K; Kanaya N; Chang G; Somlo G; Chen S
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105791. PubMed ID: 33271252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation.
    Kawanami T; Tanaka T; Hamaguchi Y; Nomiyama T; Nawata H; Yanase T
    Endocrinology; 2018 Apr; 159(4):1774-1792. PubMed ID: 29444261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
    Moss PE; Lyles BE; Stewart LV
    Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
    Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.